| ND | Neurodegenerative diseases |
| FNDC5 | Fibronectin type III domain-containing protein 5 |
| PeP | Peroxisomal protein |
| FRCP2 | Fibronectin type III repeat-containing protein 2 |
| PGC-1 α | PPARγ co-activator-1α |
| CSF | Cerebrospinal fluid |
| UCP1 | Uncoupling protein 1 |
| MAPK | Mitogen-activated protein kinases |
| AMPK | 5′ adenosine monophosphate-activated protein kinase |
| PI3K | Phosphatidylinositol 3-kinase |
| AKT | Protein kinase B |
| STAT3 | Signal transducer and activator of transcription 3 |
| cAMP | Cyclic adenosine 3′,5′-monophosphate |
| PKA | Protein kinase A |
| CREB | cAMP response element-binding protein |
| Mtss1L | Metastasis-suppressor 1-like |
| CNS | Central nervous system |
| PRRS | Pattern-recognition receptors |
| PAMPs | Pathogen-associated molecular patterns |
| DAMPs | Damage–associated molecular patterns |
| IL | Interleukin |
| TNF | Tumor necrosis factor |
| ROS | Reactive-oxygen species |
| NO | Nitric oxide |
| TLRs | Toll-like receptors |
| IFN-γ | Interferon-γ |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| BDNF | Brain-derived neurotrophic factor |
| TrkB | Tropomyosin receptor kinase B |
| ERK | Extracellular-signal-regulated kinase |
| NF-κB | Nuclear factor-kappa light chain enhancer of activated B cells |
| GSK-3 | Glycogen synthase kinase 3 |
| MKP-1 | Mitogen-activated protein kinase phosphatase 1 |
| JNK | c-Jun N-terminal kinase |
| NLRP3 | Nod-like receptor pyrin-3 |
| COX-2 | Cyclooxygenase-2 |
| Opa1 | Optic atrophy 1 |
| ALS | Amyotrophic lateral sclerosis |
| pTau | Hyperphosphorylated tau |
| Aβ | Amyloid-beta |
| APP | Amyloid precursor protein |
| BACE1 | Beta-site amyloid precursor protein cleaving enzyme 1 |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| BMSCs | Bone marrow stromal cells |